Chemical engineer fired for racist, homophobic rant onboard flight
A man hurled racist and homophobic abuse at a fellow passenger onboard an American Airlines flight from Philadelphia to Dallas.
Cheap copies Of GSK's HIV prevention drug could be ready in 2026
British drugmaker GSK has struck a deal to allow low-cost generic versions of its long-acting HIV preventive medicine to be used in the developing world.
Sanofi, GSK Variant-specific COVID Shot Found Effective Against Omicron
Late-stage data on an experimental COVID-19 vaccine from Sanofi and GSK has showed the shot confers protection against the Omicron variant of the virus, the companies said on Friday.
Coronavirus vaccine candidates from GlaxoSmithKline, Sanofi begin clinical trials
As with other vaccine candidates, if the outcome of the first two phases is acceptable, the final phase might be scheduled before the end of 2020.
-
UK govt securing 60mn more doses of virus vaccine from two pharmaceutical firms
-
GSK to sell Horlicks as it reviews UK manufacturing options
-
Weak pound boosts GSK first quarter revenue but company warns of generic competition
-
Davos 2017: GSK chief says weak pound has been a boost and wants more transparency over drug pricing
More news
GlaxoSmithKline's new asthma drug earns UK approval after price cut
While Nucala has a list price of £840 per dose, the price it will be sold to the NHS is confidential.
GlaxoSmithKline seeks FDA approval for shingles vaccine
According to analysts, Shingrix has the potential to earn $1bn annually.
UK pharmaceutical firms have weathered Brexit storms but face long-term challenges
Sector is seen as a safe haven but it faces increasing regulatory costs in the future.
GlaxoSmithKline and Alphabet's Verily partner for development of bioelectronic medicines
The new company will enable research, development and commercialisation of bioelectronic medicines.
Glaxo posts jump in profits on new drug sales
GlaxoSmithKline said development work on its new drug pipeline is starting to pay off
GSK to invest £275m in Britain in major boost to UK economy
FTSE 100 drug maker will invest across three different UK sites and create new jobs
FTSE Moves: Top flight shares edge up after Bank of England eases capital buffers
Bank of England governor Mark Carney lifts markets after easing capital requirements for lenders.
GlaxoSmithKline gel developed from a mouthwash could save thousands of babies
The antiseptic gel called Umbipro was developed in partnership with the charity Save the Children.
GlaxoSmithKline to share knowledge on cancer drugs to benefit poorer countries
The Brentford headquartered company to allow competitors access to its patent pool.
GlaxoSmithKline CEO Sir Andrew Witty to step down earlier than expected in 2017
GSK chief executive will step down in March next year after bowing to pressure from shareholders.
GlaxoSmithKline hit by £37m fine from CMA for breaching law on anticompetitive agreements
CMA sanctions £37m fine after GSK paid £50m to stifle competition on one of its drugs between 2001 and 2004.
GlaxoSmithKline 300th anniversary: From small east London pharmacy to multinational giant
In 300 years, GSK has grown from a small pharmacy to a multinational corporation.
Malaria vaccine: Mosquirix gets positive appraisal from EU regulator ahead of WHO testing
RTS,S vaccine developed by GlaxoSmithKline gets positive EMA review and next goes to WHO for tests
British investigator linked to GSK Peter Humphrey released early from Chinese jail
Humphrey's two and a half year jail sentence cut by seven months.
Goldman Sachs calls for $37bn UK funding to develop new antibiotics
A British government-backed review released on Thursday (14 May) is seeking billions of dollars to fund the development of 15 new antibiotics to counter antibiotic resistance.
GlaxoSmithKline to drive Asian business from new Singapore headquarters
GSK plans to move into a new global headquarters for Asia, located in Singapore, in 2017.
Novartis and GSK complete $20bn transactions to reform both firms
GSK and Novartis have completed several transactions totalling $20bn.
GSK profits down in 2014 after China bribery scandal
Drug firm GlaxoSmithKline paid £300m after being found guilty of bribery in China.
GlaxoSmithKline to lay off hundreds of US workers as part of £1bn cost-cutting drive
Company's Research Triangle Park site in North Carolina would be most affected with about 900 redundant jobs.
Apollo to Bid for All of GSK's Mature Drugs Worth Over $3bn
Other bidders are looking to acquire certain regional businesses.
Ebola Outbreak: GlaxoSmithKline Claims It Will Have Vaccine Within Two Months
Healthcare workers on the frontline will be offered initial stock of the vaccine.
Three Novartis Executives to Leave After Eli Lilly and GSK Deals
George Gunn, Brian McNamara and Andrin Oswald, members of Novartis executive committee, will leave firm.
- MOST READ
- 1
- 2
- 3
- 4
- 5
